NRAS and acute myeloid leukemia: Furthermore, a high-throughput drug screen tested the response of Ba/F3 cells to 843 drugs, when six different NRAS G12 mutations were introduced and showed varying results, indicating not all NRAS G12 mutations are the same [7], but more information is still needed on how different G12 mutants affect AML cells.